HomeBNKL • OTCMKTS
add
Bionik Laboratories Corp
Previous close
$0.00010
Market cap
1.25K USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2023info | Y/Y change |
|---|---|---|
Revenue | 1.81M | 41.73% |
Operating expense | 5.76M | 0.65% |
Net income | -4.95M | 52.48% |
Net profit margin | -273.99 | 66.47% |
Earnings per share | — | — |
EBITDA | -4.71M | -0.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 427.38K | -78.54% |
Total assets | 3.36M | -28.10% |
Total liabilities | 5.00M | 186.09% |
Total equity | -1.64M | — |
Shares outstanding | 12.59M | — |
Price to book | -0.00 | — |
Return on assets | -74.23% | — |
Return on capital | -161.30% | — |
Cash Flow
Net change in cash
| (USD) | 2023info | Y/Y change |
|---|---|---|
Net income | -4.95M | 52.48% |
Cash from operations | -3.39M | 18.32% |
Cash from investing | -223.69K | -1,689.55% |
Cash from financing | 2.05M | -63.06% |
Net change in cash | -1.56M | -213.08% |
Free cash flow | -1.58M | 42.09% |
About
Founded
2010
Headquarters
Website
Employees
12
